BPMC Ariel Hurley sells $118K worth of shares
Mar 08, 2025, 5:31 AM
0.00%
What does BPMC do
Blueprint Medicines, headquartered in Cambridge, Massachusetts, develops precision therapies for cancer and blood disorders, employing 645 fulltime staff. It has approved medicines like AYVAKIT and GAVRETO, with ongoing research in various cancers.
Ariel Hurley sold 1,326 shares of BPMC on 5 March at $88.80 per share, worth a total of $118K. They now own 16,944 BPMC shares, or a 7% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.